Phosphatase activity in the arterial wall after balloon injury: Effect of somatostatin analog octreotide

Laboratory Investigation

Volumn 79, Issue 8, 1999, Pages 935-944

  Yamashita, Makoto ^a   Dimayuga, Paul ^d   Kaul, Sanjay ^a   Shah, Prediman K ^a   Regnstrom, Jan ^b   Nilsson, Jan ^b   Cercek, Bojan ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE; PHOSPHATASE; SOMATOSTATIN DERIVATIVE; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY WALL; ARTICLE; BALLOON CATHETER; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE;

ANIMALS; BALLOON DILATATION; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; FEMORAL ARTERY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; OCTREOTIDE; OKADAIC ACID; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; SHP1 PROTEIN TYROSINE PHOSPHATASE; TRANSCRIPTION FACTOR AP-1;

EID: 0032788591     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Baeuerle PA (1991). The inducible transcription activator NF-κB: Regulation by distinct protein subunits. Biochim Biophys Acta 1072:63-80.
2. Bauters C, De Grotte P, Adamantidis M, Delcayre C, Hamon M, Lablanche JM, Bertrand ME, Dupuis B, and Swynghedauw B (1992). Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty? Eur Heart J 13:556-559.
3. Bellas RE, Lee JS, and Sonenshein GE (1995). Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest 96:2521-2527.
4. Bornfeld KE, Campbell JS, Koyama H, Argast GM, Leslie CC, Raines EW, Krebs EG, and Ross R (1997). The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. J Clin Invest 100:875-885.
5. Buscail L, Delesque N, Esteve J-P, Saint-Laurent N, Prats H, Clerc P, Robberecht P, Bell GI, Liebow C, Schally AV, Vaysse N, and Susini C (1994). Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: Mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Proc Natl Acad Sci USA 91:2315-2319.
6. Cercek B, Yamashita M, Dimayuga P, Zhu J, Fishbein MC, Kaul S, Shah PK, Nilsson J, and Regnstrom J (1997). Nuclear factor-κB activity and arterial response to balloon injury. Atherosclerosis 131:59-66.
7. Collins T (1993). Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 68:499-508.
8. Danielson PE, Forss-Petter S, Brow MAD, Calavetta L, Douglass J, Milner RJ, and Sutcliffe JG (1988). P1B15: A cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267.
9. Favre B, Turowski P, and Hemmings BA (1997). Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem 272:13856-13863.
10. Florio T, Scorziello A, Fattore M, D'Alto V, Salzano S, Rossi G, Berlingeri MT, Fusco A, and Schettini G (1996). Somatostatin inhibits PC C13 thyroid cell proliferation through the modulation of phosphotyrosine phosphatase activity. J Biol Chem 271:6129-6136.
11. Franklin CC, Unlap T, Adler V, and Kraft AS (1993). Multiple signal transduction pathways mediate c-jun protein phosphorylation. Cell Growth Differ 4:377-385.
12. Garton AJ and Tonks NK (1994). PTP-PEST: A protein tyrosine phosphatase regulated by serine phosphorylation. EMBOJ 13:3763-3771.
13. Haystead TAJ, Weiel JE, Lichtfield DW, Tsukitani Y, Fischer EH, and Krebs EG (1990). Okadaic acid mimics the action of insulin in stimulating protein kinase activity in isolated adipocytes. J Biol Chem 265:16571-16580.
14. Herschman HR (1991). Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60:281-319.
15. Hunter T (1995). Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signalling. Cell. 80:225-236.
16. Karin M (1995). The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270:16483-16486.
17. Lai K, Wang H, Lee W-S, Jain MK, Lee M-E, and Haber E (1996). Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J Clin Invest 98:1560-1567.
18. Landry DB, Couper LL, Bryant SR, and Lindner V (1997). Activation of the NF-κB and lkκ system in smooth muscle cells after rat arterial injury. Am J Pathol 151:1085-1095.
19. Le Romancier M, Reyl-Desmars F, Cherifi Y, Pigeon C, Bottari S, Meyer O, and Lewin MJM (1994). The 86-kDa subunit of autoantigen Ku is a somatostatin receptor regulation protein phosphatase-2A activity. J Biol Chem 269: 17464-17468.
20. Li C-CH, Dai R-M, Chen E, and Longo DL (1994). Phosphorylation of NF-κB-p50 is involved in NF-κB activation and stable DNA binding. J Biol Chem 269:30089-30092.
21. Liebow C, Lee MT, and Schally A (1990). Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase. Metabolism 39:163-166.
22. Lopez F, Esteve J-P, Buscail L, Delesque N, Saint-Laurent N, Theveniau M. Nahmias C, Vaysse N, and Susini C (1997). The tyrosine phosphatase SHP-1 associates with the sst2 soma-tostatin receptor and is an essential component of sst2-mediated inhibitory growth signaling. J Biol Chem 272: 24448-24454.
23. Menon SD, Guy GR, and Tan YH (1995). Involvement of a putative protein-tyrosine phosphatase and lκB-α serine phosphorylation in nuclear factor KB activation by tumor necrosis factor. J Biol Chem 270:18881-18887.
24. Meyer R, Hatada EN, Hohmann H-P, Haiker M, Bartsch C, Rothlisberger U, Lahm H-W, Schlaeger EJ, van Loon APGM, and Scheidereit C (1991 ). Cloning of the DNA-binding subunit of human nuclear factor κB: The level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor κ. Proc Natl Acad Sci USA 88:966-970.
25. Miano JM, Tota RR, Vlasic N, Danishefsky KJ, and Stemerman MB (1990). Early protooncogene expression in rat aortic smooth muscle cells following endothelial removal. Am J Pathol 137:761-765.
26. Moreau JP and DeFeudis FV (1987). Pharmacological studies of somatostatin and somatostatin analogues: Therapeutical advances and perspectives. Life Sci 40:419-437.
27. Park K, Chung M, and Kim S-J (1992). Inhibition of myogenesis by okadaic acid, an inhibitor of protein phosphatases, 1 and 2A, correlates with the induction of AP1. J Biol Chem 267:10810-10815.
28. Rieckmann P, Thevenin C, and Kehrl JH (1992). Okadaic acid is a potent inducer of AP-1, NF-κB, and tumor necrosis factor-α in human B Lymphocytes. Biochem Biophys Res Commun 187:51-57.
29. Rivard N, Lebel D, Laine J, and Morisset J (1994). Regulation of pancreatic tyrosine kinase and phosphatase activities by cholecystokinin and somatostatin. Am J Physiol 266:G1130-G1138.
30. Ryder K and Nathans D (1988). Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci USA 85:8464-8467.
31. Schafer H, Zheng J, Gundlach F, Gunther R, and Schmidt WE (1996). PACAP stimulates transcription of c-fos and c-jun and activates the AP-1 transcription factor in rat pancreatic carcinoma cells. Biochem Biophys Res Commun 221:111-116.
32. Singh S and Aggarwal BB (1995). Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κ-B. J Biol Chem 270:10631-10639.
33. Suganuma M, Fujuki H, Suguri H, Yoshizawa S, Hirota M, Nakayasu M, Ojika M, Wakamatsu K, Yamada K, and Sugimura T (1988). Okadaic acid: An additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85:1768-1771.
34. Sun S-C, Maggirwar SB, and Harhaj E (1995). Activation of NF-κB by phosphatase inhibitors involves the phosphorylation of IκBa at phosphatase 2A-sensitive sites. J Biol Chem 270:18347-18351.
35. Todisco A, Seva C, Takeuchi Y, Dickinson CJ, and Yamada T (1995). Somatostatin inhibits AP-1 function via multiple protein phosphatases. Am J Physiol 269:G160-G166.
36. Todisco A, Takeuchi Y, Yamada J, Sadoshima J-I, and Yamada T (1997). Molecular mechanisms for somatostatin inhibition of c-fos gene expression. Am J Physiol 272:G721-G726.
37. Viguerie N, Tahiri-Jouti N, Ayral M, Cambillau C, Scemama JL, Bastie MJ, Knuhtsen S, Esteve JP, Pradayrol L, Susini C, and Vaysee N (1989). Direct inhibitory effect of a somatostatin analog, SMS 201-995, on AR4-2J cell proliferation via pertussis toxin-sensitive guanosine triphosphate-binding protein-independent mechanism. Endocrinology 124:1017-1025.
38. Woodgett JR, Pulverer BJ, Nikolakaki E, Plyte S, Hughes K, Franklin CC, and Kraft AS (1993). Regulation of jun/AP-1 oncoproteins by protein phosphorylation. Adv Second Messenger Phosphoprotein Res 28:261-269.
39. Yumi K, Fagin JA, Yamashita M, Fishbein MC, Shah PK, Kaul S, Niu W, and Cercek B (1997). Direct effects of somatostatin analog octreotide on insulin-like growth factor-I in the arterial wall. Lab Invest 76:329-338.
40. Zeymer U, Fishbein MC, Forrester JS, and Cercek B (1992). Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Am J Pathol 141:685-689.